Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
3 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Adicet Bio, Inc.’s names, not what it holds today.
Patents granted
3
3 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
13
since 2001, to Dec 31, 2025
Names they are printed under
4
its own name, a former name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
ADICET BIO, INC. its own name
named as the applicant on its applications, in US
12 publishedADICET BIO, INC. its own name
US, as the owner printed on each patent
0 publishedRESTORBIO, INC. a former name
US, as the owner printed on each patent
0 publishedresTORbio, Inc. a former name
named as the applicant on its applications, in US
1 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Apr 12, 2022 | 11,299,708 | Methods for selective expansion of γδ T-cell populations and compositions thereof | Medical technology | ADICET BIO, INC. |
| Oct 5, 2021 | 11,135,245 | Engineered γδ T-cells | Medical technology | ADICET BIO, INC. |
| Mar 24, 2020 | 10,596,165 | Combination therapies | Pharmaceuticals | RESTORBIO, INC. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Jan 12, 2023 | 2023/0009275 | METHODS FOR EXPANDING GAMMA DELTA T-CELL POPULATIONS WITH MULTIVALENT AGENTS AND COMPOSITIONS THEREOF | Medical technology | ADICET BIO, INC. |
| Nov 24, 2022 | 2022/0372439 | METHODS FOR SELECTIVE EXPANSION OF GAMMA DELTA T-CELL POPULATIONS AND COMPOSITIONS THEREOF | Medical technology | ADICET BIO, INC. · patent 12,364,714 granted from it |
| Jul 14, 2022 | 2022/0218747 | METHODS FOR SELECTIVE IN VIVO EXPANSION OF GAMMA DELTA T-CELL POPULATIONS AND COMPOSITIONS THEREOF | Medical technology | ADICET BIO, INC. |
| May 26, 2022 | 2022/0160765 | ENGINEERED GAMMA DELTA T-CELLS | Medical technology | ADICET BIO, INC. · patent 12,371,663 granted from it |
| Dec 16, 2021 | 2021/0388111 | AFFINITY ENTITIES COMPRISING A TCR-LIKE ANTIBODY BINDING DOMAIN WITH HIGH AFFINITY AND FINE SPECIFICITY AND USES OF SAME | Biotechnology | ADICET BIO, INC. · patent 12,252,547 granted from it |
| Dec 16, 2021 | 2021/0388109 | COMPOSITIONS AND METHODS REGARDING ENGINEERED AND NON-ENGINEERED GAMMA DELTA T-CELLS FOR TREATMENT OF SOLID TUMORS | Biotechnology | ADICET BIO, INC. |
| Dec 16, 2021 | 2021/0388100 | COMPOSITIONS AND METHODS REGARDING ENGINEERED AND NON-ENGINEERED GAMMA DELTA T-CELLS FOR TREATMENT OF HEMATOLOGICAL TUMORS | Pharmaceuticals | ADICET BIO, INC. |
| Jul 2, 2020 | 2020/0207858 | ANTIBODIES CAPABLE OF BINDING HLA-A2/TYRD IN AN HLA RESTRICTED MANNER AND USES THEREOF | Pharmaceuticals | ADICET BIO, INC. · patent 11,485,785 granted from it |
| Aug 15, 2019 | 2019/0247386 | COMBINATION THERAPIES | Pharmaceuticals | resTORbio, Inc. · patent 10,596,165 granted from it |
| Apr 25, 2019 | 2019/0119634 | METHODS FOR SELECTIVE EXPANSION OF GAMMA DELTA T-CELL POPULATIONS AND COMPOSITIONS THEREOF | Medical technology | ADICET BIO, INC. · patent 11,299,708 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.